qPCR/Sequencing Assay Development to Support Vaccine Clinical Studies and Trials

acant-cooling-plate-for-qpcr-analysis-illuminated-with-blue-and-purple-lights_adobestock_1091649202

Reliable molecular assays are the foundation of successful vaccine clinical trials.

Developing robust RT-qPCR and sequencing assays requires careful planning to ensure accurate viral detection and reliable clinical data. This video discusses key considerations for molecular assay development, including target selection, assay design, analytical performance, and validation strategies that support vaccine clinical research.

Key topics include:

  • Best practices for RT-qPCR and sequencing assay development
  • Considerations for target selection and assay design
  • Strategies for optimizing analytical performance and method validation
  • The role of molecular testing in supporting vaccine clinical trials

As vaccine development continues to evolve, robust molecular assays remain essential for generating high-quality data and supporting informed clinical decisions. Discover practical approaches for developing reliable molecular testing strategies that support successful clinical research.

Complete the form below to access this video.

qPCR/Sequencing Assay Development to Support Vaccine Clinical Studies and Trials

To learn more about how Eurofins processes and protects your personal data and your rights, please read our Privacy Notice.